Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

Concentra Group Holdings Parent share price today

Concentra Group Holdings Parent, Inc. · CON · Healthcare · Medical Care Facilities · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists

Concentra Group Holdings Parent share price: $43.56 at the close on 4 November 2026, +125.2% in a year.

Turning aroundBusiness trend from fewer quarters than usual
$43.56Price +125.2% in a year
28.5×P/E higher than 100% of the last 2.3 years
$606 MRevenue (Jun 2026) +10.0% on a year ago
$63.9 MProfit (Jun 2026) +45.2% on a year ago
19.3%Operating margin +2.3 points on a year ago
39%ROE FY25
11.7%ROIC against a 6.6% cost of capital: +5.1 points

Concentra Group Holdings Parent, Inc.'s share price has risen faster than its earnings: +125.2% in a year, against −12.1% for earnings per share.

The main question: the share price moved +125.2% in a year while yearly earnings per share moved −12.1%. The difference came from the market paying a higher multiple.

The price has been rising for 24 weeks, and the P/E is higher than 100% of its own last 2.3 years. Over the last four quarters, results have been improving, with profit +45.2% on a year earlier, and 155% of the last 3 years' profit came in as cash. What will decide it: whether earnings grow into a price that has already moved.

What is the Concentra Group Holdings Parent share price today?

Concentra Group Holdings Parent, Inc.'s share price was $43.56 at the close on 4 November 2026. It has been rising for 24 weeks. That is 51.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between $19 and $44, and at that close it was at the high of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Concentra Group Holdings Parent, Inc. is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 23 weeks in a row.

1Y

Nov 2026: $43.56, 51.3% above its 200-day average. The price has been rising for 24 weeks.

  • Price $43.56
  • 50-day avg $36.70
  • 200-day avg $28.79
Nov 2026: $43.56, 51.3% above its 200-day average. The price has been rising for 24 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025$19.92$21.34$21.50
7 Nov 2025$19.34$20.92$21.43
14 Nov 2025$19.42$20.53$21.33
21 Nov 2025$20.23$20.26$21.24
28 Nov 2025$20.56$20.23$21.20
5 Dec 2025$19.47$20.15$21.12
12 Dec 2025$19.87$20.03$21.03
19 Dec 2025$19.43$19.91$20.96
26 Dec 2025$20.03$19.87$20.92
2 Jan 2026$19.41$19.85$20.90
9 Jan 2026$19.90$19.75$20.87
16 Jan 2026$21.55$19.86$20.85
23 Jan 2026$21.55$20.07$20.86
30 Jan 2026$22.18$20.30$20.89
6 Feb 2026$23.50$20.62$20.96
13 Feb 2026$23.54$20.92$21.01
20 Feb 2026$23.67$21.26$21.06
27 Feb 2026$23.96$21.65$21.11
6 Mar 2026$22.82$22.03$21.14
13 Mar 2026$22.37$22.27$21.15
20 Mar 2026$21.66$22.55$21.17
27 Mar 2026$21.12$22.70$21.17
2 Apr 2026$20.89$22.66$21.16
10 Apr 2026$21.93$22.65$21.18
17 Apr 2026$22.86$22.67$21.22
24 Apr 2026$22.82$22.58$21.28
1 May 2026$22.53$22.46$21.34
8 May 2026$24.16$22.43$21.43
15 May 2026$25.87$22.64$21.57
22 May 2026$25.32$22.95$21.71
29 May 2026$24.87$23.17$21.79
5 Jun 2026$25.32$23.48$21.84
12 Jun 2026$28.13$24.02$21.93
18 Jun 2026$28.56$24.59$22.03
26 Jun 2026$30.18$25.28$22.18
2 Jul 2026$31.91$25.92$22.35
10 Jul 2026$31.55$26.80$22.62
17 Jul 2026$31.61$27.67$22.88
24 Jul 2026$31.61$28.39$23.15
31 Jul 2026$31.65$28.99$23.43
7 Aug 2026$34.06$29.60$23.72
14 Aug 2026$35.43$30.54$24.07
21 Aug 2026$35.00$31.47$24.44
28 Aug 2026$34.26$32.14$24.83
4 Sep 2026$34.47$32.66$25.19
11 Sep 2026$34.95$33.00$25.49
18 Sep 2026$35.47$33.41$25.86
25 Sep 2026$35.01$33.77$26.24
2 Oct 2026$35.65$34.14$26.63
9 Oct 2026$37.19$34.60$27.05
16 Oct 2026$38.54$35.29$27.50
23 Oct 2026$39.25$35.78$27.99
30 Oct 2026$40.38$36.32$28.50
4 Nov 2026$43.56$36.70$28.79
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: $43.56, 51.3% above its 200-day average. The price has been rising for 24 weeks.

  • Price $43.56
  • 50-day avg $36.70
  • 200-day avg $28.79
Nov 2026: $43.56, 51.3% above its 200-day average. The price has been rising for 24 weeks.
WeekPrice50-day avg200-day avg
26 Jul 2024$22.86––
2 Aug 2024$22.65––
9 Aug 2024$22.94––
16 Aug 2024$23.41––
23 Aug 2024$23.40––
30 Aug 2024$24.45––
6 Sep 2024$24.27––
13 Sep 2024$23.12––
20 Sep 2024$22.86––
27 Sep 2024$22.42––
4 Oct 2024$20.97$22.96–
11 Oct 2024$20.09$22.65–
18 Oct 2024$21.24$22.52–
25 Oct 2024$20.91$22.34–
1 Nov 2024$20.08$22.05–
8 Nov 2024$19.63$21.70–
15 Nov 2024$20.53$21.32–
22 Nov 2024$21.90$21.14–
29 Nov 2024$21.82$21.07–
6 Dec 2024$20.27$20.87–
13 Dec 2024$20.50$20.72–
20 Dec 2024$20.03$20.74–
27 Dec 2024$20.39$20.70–
3 Jan 2025$19.60$20.58–
10 Jan 2025$19.73$20.48–
17 Jan 2025$21.13$20.53–
24 Jan 2025$23.52$20.78–
31 Jan 2025$23.31$21.10–
7 Feb 2025$22.78$21.30–
14 Feb 2025$22.72$21.36–
21 Feb 2025$22.96$21.55–
28 Feb 2025$22.58$21.81–
7 Mar 2025$22.23$22.05–
14 Mar 2025$20.79$22.11–
21 Mar 2025$20.82$22.25–
28 Mar 2025$21.44$22.37–
4 Apr 2025$20.61$22.34–
11 Apr 2025$20.29$22.03–
17 Apr 2025$20.39$21.82–
25 Apr 2025$21.25$21.61–
2 May 2025$21.78$21.47–
9 May 2025$21.40$21.32–
16 May 2025$22.72$21.26$21.69
23 May 2025$21.14$21.32$21.67
30 May 2025$21.63$21.37$21.65
6 Jun 2025$22.03$21.42$21.61
13 Jun 2025$21.45$21.41$21.58
20 Jun 2025$20.74$21.44$21.53
27 Jun 2025$21.15$21.46$21.45
3 Jul 2025$20.56$21.49$21.41
11 Jul 2025$19.90$21.38$21.34
18 Jul 2025$19.56$21.19$21.26
25 Jul 2025$19.66$21.03$21.22
1 Aug 2025$19.48$20.79$21.22
8 Aug 2025$21.62$20.67$21.20
15 Aug 2025$23.24$20.78$21.24
22 Aug 2025$23.65$20.90$21.31
29 Aug 2025$23.80$21.11$21.40
5 Sep 2025$23.09$21.32$21.46
12 Sep 2025$22.15$21.46$21.49
19 Sep 2025$20.66$21.52$21.46
26 Sep 2025$20.82$21.60$21.46
3 Oct 2025$20.75$21.70$21.47
10 Oct 2025$20.31$21.77$21.48
17 Oct 2025$19.92$21.79$21.48
24 Oct 2025$20.91$21.61$21.50
31 Oct 2025$19.92$21.34$21.50
7 Nov 2025$19.34$20.92$21.43
14 Nov 2025$19.42$20.53$21.33
21 Nov 2025$20.23$20.26$21.24
28 Nov 2025$20.56$20.23$21.20
5 Dec 2025$19.47$20.15$21.12
12 Dec 2025$19.87$20.03$21.03
19 Dec 2025$19.43$19.91$20.96
26 Dec 2025$20.03$19.87$20.92
2 Jan 2026$19.41$19.85$20.90
9 Jan 2026$19.90$19.75$20.87
16 Jan 2026$21.55$19.86$20.85
23 Jan 2026$21.55$20.07$20.86
30 Jan 2026$22.18$20.30$20.89
6 Feb 2026$23.50$20.62$20.96
13 Feb 2026$23.54$20.92$21.01
20 Feb 2026$23.67$21.26$21.06
27 Feb 2026$23.96$21.65$21.11
6 Mar 2026$22.82$22.03$21.14
13 Mar 2026$22.37$22.27$21.15
20 Mar 2026$21.66$22.55$21.17
27 Mar 2026$21.12$22.70$21.17
2 Apr 2026$20.89$22.66$21.16
10 Apr 2026$21.93$22.65$21.18
17 Apr 2026$22.86$22.67$21.22
24 Apr 2026$22.82$22.58$21.28
1 May 2026$22.53$22.46$21.34
8 May 2026$24.16$22.43$21.43
15 May 2026$25.87$22.64$21.57
22 May 2026$25.32$22.95$21.71
29 May 2026$24.87$23.17$21.79
5 Jun 2026$25.32$23.48$21.84
12 Jun 2026$28.13$24.02$21.93
18 Jun 2026$28.56$24.59$22.03
26 Jun 2026$30.18$25.28$22.18
2 Jul 2026$31.91$25.92$22.35
10 Jul 2026$31.55$26.80$22.62
17 Jul 2026$31.61$27.67$22.88
24 Jul 2026$31.61$28.39$23.15
31 Jul 2026$31.65$28.99$23.43
7 Aug 2026$34.06$29.60$23.72
14 Aug 2026$35.43$30.54$24.07
21 Aug 2026$35.00$31.47$24.44
28 Aug 2026$34.26$32.14$24.83
4 Sep 2026$34.47$32.66$25.19
11 Sep 2026$34.95$33.00$25.49
18 Sep 2026$35.47$33.41$25.86
25 Sep 2026$35.01$33.77$26.24
2 Oct 2026$35.65$34.14$26.63
9 Oct 2026$37.19$34.60$27.05
16 Oct 2026$38.54$35.29$27.50
23 Oct 2026$39.25$35.78$27.99
30 Oct 2026$40.38$36.32$28.50
4 Nov 2026$43.56$36.70$28.79
Weekly closing price ($) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 2-year window.

Price stage: Falling from Dec 2025 to Jan 2026; Sideways from Jan 2026 to May 2026; Rising from May 2026 to Nov 2026.

Price stage: Falling from Dec 2025 to Jan 2026; Sideways from Jan 2026 to May 2026; Rising from May 2026 to Nov 2026.

Week by week since 2024: did it beat the S&P 500 over the past 13 weeks?

Ahead in 56 of 107 weeks

Week by week since 2024: did it beat the S&P 500 over the past 13 weeks?
Week13-week return vs S&P 500
26 Jul 2024no S&P 500 reading
2 Aug 2024no S&P 500 reading
9 Aug 2024no S&P 500 reading
16 Aug 2024no S&P 500 reading
23 Aug 2024no S&P 500 reading
30 Aug 2024no S&P 500 reading
6 Sep 2024no S&P 500 reading
13 Sep 2024no S&P 500 reading
20 Sep 2024no S&P 500 reading
27 Sep 2024no S&P 500 reading
4 Oct 2024no S&P 500 reading
11 Oct 2024no S&P 500 reading
18 Oct 2024no S&P 500 reading
25 Oct 2024−14.9%
1 Nov 2024−18.5%
8 Nov 2024−26.7%
15 Nov 2024−18.0%
22 Nov 2024−12.3%
29 Nov 2024−17.7%
6 Dec 2024−29.0%
13 Dec 2024−18.8%
20 Dec 2024−16.4%
27 Dec 2024−13.2%
3 Jan 2025−9.8%
10 Jan 2025−1.9%
17 Jan 2025−2.7%
24 Jan 2025+7.5%
31 Jan 2025+10.7%
7 Feb 2025+15.6%
14 Feb 2025+6.6%
21 Feb 2025+4.1%
28 Feb 2025+4.9%
7 Mar 2025+14.9%
14 Mar 2025+8.3%
21 Mar 2025+8.5%
28 Mar 2025+11.8%
4 Apr 2025+19.8%
11 Apr 2025+10.9%
17 Apr 2025+8.4%
25 Apr 2025−0.2%
2 May 2025−0.7%
9 May 2025+0.0%
16 May 2025+2.5%
23 May 2025−4.5%
30 May 2025−3.4%
6 Jun 2025−4.9%
13 Jun 2025−2.9%
20 Jun 2025−5.8%
27 Jun 2025−12.0%
3 Jul 2025−24.0%
11 Jul 2025−18.7%
18 Jul 2025−23.3%
25 Jul 2025−23.2%
1 Aug 2025−20.3%
8 Aug 2025−11.9%
15 Aug 2025−6.0%
22 Aug 2025+0.4%
29 Aug 2025+0.6%
5 Sep 2025−3.2%
12 Sep 2025−6.9%
19 Sep 2025−12.1%
26 Sep 2025−9.2%
3 Oct 2025−6.1%
10 Oct 2025−2.7%
17 Oct 2025−4.0%
24 Oct 2025+0.1%
31 Oct 2025−7.4%
7 Nov 2025−15.8%
14 Nov 2025−20.9%
21 Nov 2025−16.6%
28 Nov 2025−19.6%
5 Dec 2025−21.6%
12 Dec 2025−14.0%
19 Dec 2025−8.5%
26 Dec 2025−8.1%
2 Jan 2026−8.5%
9 Jan 2026−8.3%
16 Jan 2026+4.1%
23 Jan 2026+1.3%
30 Jan 2026+9.9%
6 Feb 2026+18.6%
13 Feb 2026+19.8%
20 Feb 2026+12.4%
27 Feb 2026+16.2%
6 Mar 2026+19.1%
13 Mar 2026+15.4%
20 Mar 2026+16.2%
27 Mar 2026+13.6%
2 Apr 2026+11.6%
10 Apr 2026+12.3%
17 Apr 2026+3.4%
24 Apr 2026+2.3%
1 May 2026−2.6%
8 May 2026−4.0%
15 May 2026+1.5%
22 May 2026−1.2%
29 May 2026−6.5%
5 Jun 2026+1.3%
12 Jun 2026+13.8%
18 Jun 2026+16.7%
26 Jun 2026+27.9%
2 Jul 2026+39.2%
10 Jul 2026+32.8%
17 Jul 2026+33.6%
24 Jul 2026+35.0%
31 Jul 2026+36.8%
7 Aug 2026+36.1%
14 Aug 2026+31.9%
21 Aug 2026+35.5%
28 Aug 2026+36.1%
4 Sep 2026+31.7%
11 Sep 2026+21.2%
18 Sep 2026+22.2%
25 Sep 2026+10.2%
2 Oct 2026+8.4%
9 Oct 2026+14.7%
16 Oct 2026+19.2%
23 Oct 2026+21.3%
30 Oct 2026+26.4%
4 Nov 2026+28.7%
Each bar is one week, from 2024 to now (107 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the S&P 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 2.3 years the share price moved +91% while the S&P 500 moved +41%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What dividend does Concentra Group Holdings Parent pay?

Concentra Group Holdings Parent, Inc. paid $0.25 per share over the last four reported quarters. The most recent declaration was $0.06 for Jun 2026. At today's price of $43.56 that is a yield of 0.57%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

Dividend per share each quarter: latest $0.06 (Jun 2026)

  • Dividend per share $0.06
Dividend per share each quarter: latest $0.06 (Jun 2026)
QuarterDividend per share
Dec 2024$0.06
Mar 2025$0.06
Jun 2025$0.06
Sep 2025$0.06
Dec 2025$0.06
Mar 2026$0.06
Jun 2026$0.06
Declared dividend per share, $ a share, each reported quarter. 7 quarters on file.

Which stock lists is Concentra Group Holdings Parent on?

Concentra Group Holdings Parent is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Is Concentra Group Holdings Parent profitable?

Concentra Group Holdings Parent, Inc. earned $63.9 M of net profit in the Jun 2026 quarter, +45.2% on the same quarter a year earlier. That is the 4th quarter in a row of profit growth. Full-year FY25 profit was $164 M. Over 4 years profit has grown −5.4% a year on average. That is 10.5% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned $44.0 M.

For the full year, FY25 profit was $164 M (−1.3% on the year before).

FY25 profit $164 M (−1.3% on the year before), −5.4% a year over 4 years

  • Net profit $164 M
FY25 profit $164 M (−1.3% on the year before), −5.4% a year over 4 years
QuarterNet profit
FY21$205 M
FY22$166 M
FY23$180 M
FY24$166 M
FY25$164 M

Growth on a year earlier

  • Growth on a year earlier −1.3%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22−19%
FY238.3%
FY24−7.4%
FY25−1.3%
Top: net profit each year, $ M. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $63.9 M (+45.2% on a year earlier), the 4th quarter in a row of growth

  • Net profit (quarterly) $63.9 M
Jun 2026: $63.9 M (+45.2% on a year earlier), the 4th quarter in a row of growth
QuarterNet profit (quarterly)
Sep 2023$53.0 M
Dec 2023$27.9 M
Mar 2024$49.0 M
Jun 2024$51.7 M
Sep 2024$44.3 M
Dec 2024$21.3 M
Mar 2025$38.5 M
Jun 2025$44.0 M
Sep 2025$47.7 M
Dec 2025$34.0 M
Mar 2026$49.4 M
Jun 2026$63.9 M

Growth on a year earlier

  • Growth on a year earlier 45.2%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023–
Dec 2023–
Mar 20246.1%
Jun 2024−1.6%
Sep 2024−16.4%
Dec 2024−23.6%
Mar 2025−21.4%
Jun 2025−14.9%
Sep 20257.6%
Dec 202559.6%
Mar 202628.5%
Jun 202645.2%
Top: net profit each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +10.0% on a year earlier and the margin moved +2.3 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed +35.2% and revenue +14.1%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit.

How much revenue does Concentra Group Holdings Parent make, and is it growing?

Concentra Group Holdings Parent, Inc. reported $606 M of revenue in the Jun 2026 quarter, +10.0% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 4 years it has grown 5.7% a year on average. The last full year, FY25, came in at $2.2 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $2.3 B.

FY25 revenue was $2.2 B, +13.9% on the year before.

FY25 revenue $2.2 B (+13.9% on the year before), 5.7% a year over 4 years

  • Revenue $2.2 B
FY25 revenue $2.2 B (+13.9% on the year before), 5.7% a year over 4 years
QuarterRevenue
FY21$1.7 B
FY22$1.7 B
FY23$1.8 B
FY24$1.9 B
FY25$2.2 B

Growth on a year earlier

  • Growth on a year earlier 13.9%
Growth on a year earlier
QuarterGrowth on a year earlier
FY21–
FY22−0.4%
FY236.6%
FY243.4%
FY2513.9%
Top: revenue each year, $ B. Below: growth on the year before, %. 5-year window. A grey bar is lower than the year before.

Jun 2026: $606 M (+10.0% on a year earlier), the 10th quarter in a row of growth

  • Revenue (quarterly) $606 M
Jun 2026: $606 M (+10.0% on a year earlier), the 10th quarter in a row of growth
QuarterRevenue (quarterly)
Sep 2023$474 M
Dec 2023$441 M
Mar 2024$468 M
Jun 2024$478 M
Sep 2024$490 M
Dec 2024$465 M
Mar 2025$501 M
Jun 2025$551 M
Sep 2025$573 M
Dec 2025$539 M
Mar 2026$570 M
Jun 2026$606 M

Growth on a year earlier

  • Growth on a year earlier 10%
Growth on a year earlier
QuarterGrowth on a year earlier
Sep 2023–
Dec 2023–
Mar 20242.5%
Jun 20242.3%
Sep 20243.3%
Dec 20245.5%
Mar 20257.1%
Jun 202515.2%
Sep 202517%
Dec 202515.9%
Mar 202613.7%
Jun 202610%
Top: revenue each quarter, $ M. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +14.1% on average, against 5.7% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +14.0%, against +10.9% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +31.7%, against +3.6% a year (accelerating).

How much of every $100 of sales does Concentra Group Holdings Parent keep?

Concentra Group Holdings Parent, Inc.'s operating margin was 19.3% in the Jun 2026 quarter, 2.3 percentage points higher than the same quarter a year ago. Across 5 years it has been between 15.0% and 21.9%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +2.3 percentage points on the year while gross margin changed +2.4 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

FY25: 16.0%, within a range of 15.0% to 21.9% over 5 years

  • Operating margin 16.0%
FY25: 16.0%, within a range of 15.0% to 21.9% over 5 years
QuarterOperating margin
FY2121.9%
FY2215%
FY2315.6%
FY2416.2%
FY2516%

Change on the year before (points)

  • Change on the year before (points) −0.2 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY21–
FY22−6.9 pts
FY23+0.6 pts
FY24+0.6 pts
FY25−0.2 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 5-year window.

Jun 2026: operating margin 19.3% (+2.3 points on a year earlier)

  • Operating margin 19.3%
Jun 2026: operating margin 19.3% (+2.3 points on a year earlier)
QuarterOperating margin
Sep 202317.1%
Dec 202311.2%
Mar 202416.6%
Jun 202417.5%
Sep 202417.6%
Dec 202412.9%
Mar 202516.7%
Jun 202517%
Sep 202516.9%
Dec 202513.2%
Mar 202617%
Jun 202619.3%

Change on a year earlier (points)

  • Change on a year earlier (points) +2.3 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Sep 2023–
Dec 2023–
Mar 2024+0.1 pts
Jun 2024−0.1 pts
Sep 2024+0.5 pts
Dec 2024+1.7 pts
Mar 2025+0.1 pts
Jun 2025−0.5 pts
Sep 2025−0.7 pts
Dec 2025+0.3 pts
Mar 2026+0.3 pts
Jun 2026+2.3 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is Concentra Group Holdings Parent's profit turning into cash?

Over the last 3 years, 155% of Concentra Group Holdings Parent, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $279 M of operating cash against $164 M of profit. After $82.3 M of spending on assets, $197 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY25: operating cash $279 M against profit $164 M; 155% of 3 years' profit came in as cash

  • Operating cash $279 M
  • Net profit $164 M
  • Free cash $197 M
FY25: operating cash $279 M against profit $164 M; 155% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY21$291 M$205 M$244 M
FY22$274 M$166 M$228 M
FY23$234 M$180 M$169 M
FY24$275 M$166 M$210 M
FY25$279 M$164 M$197 M
Operating cash flow and net profit each year, $ M. The line is free cash flow: operating cash minus spending on assets. 5-year window, yearly figures.

Jun 2026: operating cash $135 M = 212% of the quarter's profit

  • Operating cash (quarterly) $135 M
Jun 2026: operating cash $135 M = 212% of the quarter's profit
QuarterOperating cash (quarterly)
Sep 2023$58.6 M
Dec 2023$76.2 M
Mar 2024$44.6 M
Jun 2024$70.4 M
Sep 2024$65.9 M
Dec 2024$93.7 M
Mar 2025$11.7 M
Jun 2025$88.4 M
Sep 2025$60.6 M
Dec 2025$119 M
Mar 2026$21.0 M
Jun 2026$135 M

Operating cash as % of profit

  • Operating cash as % of profit 212%
Operating cash as % of profit
QuarterOperating cash as % of profit
Sep 2023110%
Dec 2023273%
Mar 202491%
Jun 2024136%
Sep 2024149%
Dec 2024440%
Mar 202530%
Jun 2025201%
Sep 2025127%
Dec 2025349%
Mar 202643%
Jun 2026212%
Top: operating cash each quarter, $ M. Below: operating cash as a % of net profit; 100% means all of the quarter's profit came in as cash. Last 12 quarters.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

Where does Concentra Group Holdings Parent's cash go?

Concentra Group Holdings Parent, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $212 M on assets over the last 3 years. Averaged over those years that is 3.3% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $212 M over the last 3 years.

FY25: capex $82.3 M, steady spending

  • Capex $82.3 M
FY25: capex $82.3 M, steady spending
QuarterCapex
FY21$46.8 M
FY22$46.0 M
FY23$65.0 M
FY24$64.3 M
FY25$82.3 M
Capital spending each year, $ M.

Jun 2026: capex $15.7 M in the quarter

  • Capex (quarterly) $15.7 M
Jun 2026: capex $15.7 M in the quarter
QuarterCapex (quarterly)
Sep 2023$15.5 M
Dec 2023$23.6 M
Mar 2024$17.2 M
Jun 2024$15.3 M
Sep 2024$15.1 M
Dec 2024$16.7 M
Mar 2025$15.7 M
Jun 2025$25.2 M
Sep 2025$21.2 M
Dec 2025$20.2 M
Mar 2026$11.1 M
Jun 2026$15.7 M

Free cash

  • Free cash $120 M
Free cash
QuarterFree cash
Sep 2023$43.1 M
Dec 2023$52.5 M
Mar 2024$27.4 M
Jun 2024$55.2 M
Sep 2024$50.8 M
Dec 2024$77.0 M
Mar 2025−$4.0 M
Jun 2025$63.2 M
Sep 2025$39.4 M
Dec 2025$98.5 M
Mar 2026$9.9 M
Jun 2026$120 M
Top: capital spending each quarter, $ M. Below: free cash flow, $ M. Last 12 quarters.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is Concentra Group Holdings Parent's P/E ratio, and how does it compare with its own history?

Concentra Group Holdings Parent, Inc.'s P/E is 28.5×, about the highest it has ever been. Its usual P/E (the middle reading) is 16.5×, over 2.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

P/E 28.5× against a usual 16.5×: about the highest it has ever been

  • P/E 25.3×
  • Median 16.5×
P/E 28.5× against a usual 16.5×: about the highest it has ever been
WeekP/EMedian
26 Jul 202413.1×16.5×
2 Aug 202413.0×16.5×
9 Aug 202413.2×16.5×
16 Aug 202413.4×16.5×
23 Aug 202413.4×16.5×
30 Aug 202414.0×16.5×
6 Sep 202413.9×16.5×
13 Sep 202413.3×16.5×
20 Sep 202413.1×16.5×
27 Sep 202412.8×16.5×
4 Oct 202413.1×16.5×
11 Oct 202412.5×16.5×
18 Oct 202413.3×16.5×
25 Oct 202413.1×16.5×
1 Nov 202412.5×16.5×
8 Nov 202412.3×16.5×
15 Nov 202412.8×16.5×
22 Nov 202413.7×16.5×
29 Nov 202413.6×16.5×
6 Dec 202412.7×16.5×
13 Dec 202412.8×16.5×
20 Dec 202412.5×16.5×
27 Dec 202412.7×16.5×
3 Jan 202513.1×16.5×
10 Jan 202513.1×16.5×
17 Jan 202514.1×16.5×
24 Jan 202515.7×16.5×
31 Jan 202515.5×16.5×
7 Feb 202515.2×16.5×
14 Feb 202515.1×16.5×
21 Feb 202515.3×16.5×
28 Feb 202515.0×16.5×
7 Mar 202514.8×16.5×
14 Mar 202513.8×16.5×
21 Mar 202513.9×16.5×
28 Mar 202514.3×16.5×
4 Apr 202515.4×16.5×
11 Apr 202515.2×16.5×
17 Apr 202515.3×16.5×
25 Apr 202515.9×16.5×
2 May 202516.3×16.5×
9 May 202516.0×16.5×
16 May 202517.0×16.5×
23 May 202515.8×16.5×
30 May 202516.2×16.5×
6 Jun 202516.5×16.5×
13 Jun 202516.1×16.5×
20 Jun 202515.5×16.5×
27 Jun 202515.8×16.5×
3 Jul 202517.3×16.5×
11 Jul 202516.8×16.5×
18 Jul 202516.5×16.5×
25 Jul 202516.6×16.5×
1 Aug 202516.4×16.5×
8 Aug 202518.2×16.5×
15 Aug 202519.6×16.5×
22 Aug 202519.9×16.5×
29 Aug 202520.1×16.5×
5 Sep 202519.5×16.5×
12 Sep 202518.7×16.5×
19 Sep 202517.4×16.5×
26 Sep 202517.6×16.5×
3 Oct 202517.4×16.5×
10 Oct 202517.0×16.5×
17 Oct 202516.7×16.5×
24 Oct 202517.5×16.5×
31 Oct 202516.7×16.5×
7 Nov 202516.2×16.5×
14 Nov 202516.3×16.5×
21 Nov 202516.9×16.5×
28 Nov 202517.2×16.5×
5 Dec 202516.3×16.5×
12 Dec 202516.6×16.5×
19 Dec 202516.3×16.5×
26 Dec 202516.8×16.5×
2 Jan 202615.0×16.5×
9 Jan 202615.3×16.5×
16 Jan 202616.6×16.5×
23 Jan 202616.6×16.5×
30 Jan 202617.1×16.5×
6 Feb 202618.1×16.5×
13 Feb 202618.2×16.5×
20 Feb 202618.3×16.5×
27 Feb 202618.5×16.5×
6 Mar 202617.6×16.5×
13 Mar 202617.3×16.5×
20 Mar 202616.7×16.5×
27 Mar 202616.3×16.5×
2 Apr 202615.1×16.5×
10 Apr 202615.8×16.5×
17 Apr 202616.5×16.5×
24 Apr 202616.5×16.5×
1 May 202616.3×16.5×
8 May 202617.4×16.5×
15 May 202618.7×16.5×
22 May 202618.3×16.5×
29 May 202618.0×16.5×
5 Jun 202618.3×16.5×
12 Jun 202620.3×16.5×
18 Jun 202620.6×16.5×
26 Jun 202621.8×16.5×
2 Jul 202620.6×16.5×
10 Jul 202620.4×16.5×
17 Jul 202620.4×16.5×
24 Jul 202620.4×16.5×
31 Jul 202620.4×16.5×
7 Aug 202622.0×16.5×
14 Aug 202622.9×16.5×
21 Aug 202622.6×16.5×
28 Aug 202622.1×16.5×
4 Sep 202622.3×16.5×
11 Sep 202622.6×16.5×
18 Sep 202622.9×16.5×
25 Sep 202622.6×16.5×
2 Oct 202623.0×16.5×
9 Oct 202624.0×16.5×
16 Oct 202624.9×16.5×
23 Oct 202625.3×16.5×
30 Oct 202625.3×16.5×
4 Nov 202625.3×16.5×

Earnings per share, 12 months

  • Earnings per share, 12 months $1.55
Earnings per share, 12 months
WeekEarnings per share, 12 months
26 Jul 2024–
2 Aug 2024–
9 Aug 2024–
16 Aug 2024–
23 Aug 2024–
30 Aug 2024–
6 Sep 2024–
13 Sep 2024–
20 Sep 2024–
27 Sep 2024$1.75
4 Oct 2024$1.75
11 Oct 2024$1.75
18 Oct 2024$1.75
25 Oct 2024$1.75
1 Nov 2024$1.75
8 Nov 2024$1.75
15 Nov 2024$1.75
22 Nov 2024$1.75
29 Nov 2024$1.75
6 Dec 2024$1.75
13 Dec 2024$1.75
20 Dec 2024$1.75
27 Dec 2024$1.60
3 Jan 2025$1.60
10 Jan 2025$1.60
17 Jan 2025$1.60
24 Jan 2025$1.60
31 Jan 2025$1.60
7 Feb 2025$1.60
14 Feb 2025$1.60
21 Feb 2025$1.60
28 Feb 2025$1.60
7 Mar 2025$1.60
14 Mar 2025$1.60
21 Mar 2025$1.60
28 Mar 2025$1.50
4 Apr 2025$1.50
11 Apr 2025$1.50
17 Apr 2025$1.50
25 Apr 2025$1.50
2 May 2025$1.50
9 May 2025$1.50
16 May 2025$1.50
23 May 2025$1.50
30 May 2025$1.50
6 Jun 2025$1.50
13 Jun 2025$1.50
20 Jun 2025$1.50
27 Jun 2025$1.33
3 Jul 2025$1.33
11 Jul 2025$1.33
18 Jul 2025$1.33
25 Jul 2025$1.33
1 Aug 2025$1.33
8 Aug 2025$1.33
15 Aug 2025$1.33
22 Aug 2025$1.33
29 Aug 2025$1.33
5 Sep 2025$1.33
12 Sep 2025$1.33
19 Sep 2025$1.33
26 Sep 2025$1.19
3 Oct 2025$1.19
10 Oct 2025$1.19
17 Oct 2025$1.19
24 Oct 2025$1.19
31 Oct 2025$1.19
7 Nov 2025$1.19
14 Nov 2025$1.19
21 Nov 2025$1.19
28 Nov 2025$1.19
5 Dec 2025$1.19
12 Dec 2025$1.19
19 Dec 2025$1.19
26 Dec 2025$1.20
2 Jan 2026$1.20
9 Jan 2026$1.20
16 Jan 2026$1.20
23 Jan 2026$1.20
30 Jan 2026$1.20
6 Feb 2026$1.20
13 Feb 2026$1.20
20 Feb 2026$1.20
27 Feb 2026$1.20
6 Mar 2026$1.20
13 Mar 2026$1.20
20 Mar 2026$1.20
27 Mar 2026$1.30
2 Apr 2026$1.30
10 Apr 2026$1.30
17 Apr 2026$1.30
24 Apr 2026$1.30
1 May 2026$1.30
8 May 2026$1.30
15 May 2026$1.30
22 May 2026$1.30
29 May 2026$1.30
5 Jun 2026$1.30
12 Jun 2026$1.30
18 Jun 2026$1.30
26 Jun 2026$1.39
2 Jul 2026$1.39
10 Jul 2026$1.39
17 Jul 2026$1.39
24 Jul 2026$1.39
31 Jul 2026$1.39
7 Aug 2026$1.39
14 Aug 2026$1.39
21 Aug 2026$1.39
28 Aug 2026$1.39
4 Sep 2026$1.39
11 Sep 2026$1.39
18 Sep 2026$1.39
25 Sep 2026$1.55
2 Oct 2026$1.55
9 Oct 2026$1.55
16 Oct 2026$1.55
23 Oct 2026$1.55
30 Oct 2026$1.55
4 Nov 2026$1.55
Top: P/E each week. Below: earnings per share, trailing twelve months, a step line that moves once a quarter; 2.3 years of history; short peaks above 25× are drawn at the top edge.

PEG 1.32 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate

  • PEG 1.32×
  • PEG = 1.0 1.00×
PEG 1.32 at the Jun 2026 quarter end: above 1.0, so the P/E is bigger than the earnings growth rate
QuarterPEGPEG = 1.0
Mar 20252.19×1.00×
Jun 20251.89×1.00×
Sep 20251.75×1.00×
Dec 20252.15×1.00×
Mar 20261.09×1.00×
Jun 20261.32×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Last 6 quarters.
28.5×P/E · higher than 100% of its last 2.3 years
1.52PEG · today, as reported

Why the multiple is where it is: over the past year earnings per share moved −12.1% while the price moved +125.2%. The price did better than earnings, which pushed the multiple up within its own range.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Is the Concentra Group Holdings Parent business getting better or worse?

Concentra Group Holdings Parent, Inc.'s business is turning around. Profit growth has swung from −21.4% at its low to +45.2%, rising from a low 5 quarters ago (from single-quarter figures), with ROCE steady at 14.8%. This is based on 11 quarters of 3 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +13.9% in FY25, profit −1.3%

  • Revenue growth 13.9%
Growth year by year: revenue +13.9% in FY25, profit −1.3%
QuarterRevenue growth
FY21–
FY22−0.4%
FY236.6%
FY243.4%
FY2513.9%

Profit growth, EPS growth

  • Profit growth −1.3%
  • EPS growth −12.1%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY21––
FY22−19%−19.6%
FY238.3%7.9%
FY24−7.4%−15.5%
FY25−1.3%−12.1%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue accelerating, profit accelerating

  • Revenue 10%
Three growth lines over twelve quarters: revenue accelerating, profit accelerating
QuarterRevenue
Sep 2023–
Dec 2023–
Mar 20242.5%
Jun 20242.3%
Sep 20243.3%
Dec 20245.5%
Mar 20257.1%
Jun 202515.2%
Sep 202517%
Dec 202515.9%
Mar 202613.7%
Jun 202610%

Profit, EPS

  • Profit 45.2%
  • EPS 30.6%
Profit, EPS
QuarterProfitEPS
Sep 2023––
Dec 2023––
Mar 20246.1%–
Jun 2024−1.6%–
Sep 2024−16.4%–
Dec 2024−23.6%−13%
Mar 2025−21.4%−23.9%
Jun 2025−14.9%−32%
Sep 20257.6%−25.4%
Dec 202559.6%−13.7%
Mar 202628.5%3.7%
Jun 202645.2%30.6%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. Where the 12-month history is short, the line uses single-quarter growth instead, which is noisier; extreme jumps from a tiny base are evened out before reading. A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 14.8%
ROCE: the return line, worked out each quarter
QuarterROCE
Sep 2023–
Dec 202314%
Mar 202414.1%
Jun 202414.2%
Sep 202414%
Dec 202414.4%
Mar 202513.9%
Jun 202514.1%
Sep 202514.1%
Dec 202514.6%
Mar 202614.4%
Jun 202614.8%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
Steady highRevenue growth · latest +10.0%, range +2.3% to +17.0%
RisingProfit growth · latest +45.2%, range −23.6% to +45.2%
Stuck lowROCE · latest 14.8%, range 13.9% to 14.8%

Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it.

One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.

This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+13.9%+7.9%——
Profit−1.3%−0.3%——
EPS−12.1%−7.1%——
Stock price+125.2%———
+10.0%Revenue growth (Jun 2026) · latest quarter against a year ago
+45.2%Profit growth (Jun 2026) · latest quarter against a year ago
5.7%Revenue, 4 years · yearly growth over the long run

How much does Concentra Group Holdings Parent earn on its capital?

Concentra Group Holdings Parent, Inc. earned a ROE of 39% in FY25. That is up from a low of 15% in FY23. Its return on capital used (ROIC) is 5.1 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 7.6% net margin and 0.76× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 7.6% net margin × 0.76× asset turnover × 6.80× leverage (assets divided by equity) ≈ 39.3% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 11.7% − 6.6% = +5.1 percentage points. The 6.6% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value.

FY25: ROE 39%, the climb back from FY23's 15%

  • ROE 39%
  • ROIC (annual) 11.8%
  • Cost of capital 6.6%
FY25: ROE 39%, the climb back from FY23's 15%
QuarterROEROIC (annual)Cost of capital
FY2216.7%9.9%6.6%
FY2315.3%10.8%6.6%
FY2455.7%11.1%6.6%
FY2539%11.8%6.6%
Return on equity each year, % (line); ROIC each year, % (line). 4-year window, low years included. The flat line is the 6.6% cost of capital used on this page.

Jun 2026: ROIC 11.1% (last 12 months) against a 6.6% cost of capital

  • ROIC (12 months) 11.1%
  • ROE (12 months) 47.8%
  • Cost of capital 6.6%
Jun 2026: ROIC 11.1% (last 12 months) against a 6.6% cost of capital
QuarterROIC (12 months)ROE (12 months)Cost of capital
Sep 2022–0%6.6%
Dec 2022–0%6.6%
Jun 2024–16.8%6.6%
Sep 20245.9%17%6.6%
Dec 20248.9%23.3%6.6%
Mar 202510.9%30.4%6.6%
Jun 202510.8%51.6%6.6%
Sep 202510.7%52.9%6.6%
Dec 202510.6%51.3%6.6%
Mar 202611%34.9%6.6%
Jun 202611.1%47.8%6.6%
ROIC and ROE over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 11 quarters, lined up with the yearly figure.

Does Concentra Group Holdings Parent have too much debt?

Concentra Group Holdings Parent, Inc. has total debt of $2.1 B against shareholder equity of $506 M as of Jun 2026, so its debt is 4.23× its equity. Year by year, that ratio went from 1.04 in FY22 to 5.01 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY25: debt $2.1 B, 5.01× equity

  • Total debt $2.1 B
FY25: debt $2.1 B, 5.01× equity
QuarterTotal debt
FY22$1.0 B
FY23$905 M
FY24$2.0 B
FY25$2.1 B

Debt-to-equity

  • Debt-to-equity 5.01×
Debt-to-equity
QuarterDebt-to-equity
FY221.04×
FY230.77×
FY246.53×
FY255.01×
Top: total debt each year, $ B. Below: debt-to-equity, ×. 4-year window.

Jun 2026: debt $2.1 B, debt-to-equity 4.23

  • Total debt (quarterly) $2.1 B
Jun 2026: debt $2.1 B, debt-to-equity 4.23
QuarterTotal debt (quarterly)
Mar 2023$1.0 B
Dec 2023$905 M
Mar 2024$907 M
Jun 2024$861 M
Sep 2024$1.9 B
Dec 2024$2.0 B
Mar 2025$2.1 B
Jun 2025$2.2 B
Sep 2025$2.1 B
Dec 2025$2.1 B
Mar 2026$2.1 B
Jun 2026$2.1 B

Debt-to-equity

  • Debt-to-equity 4.23×
Debt-to-equity
QuarterDebt-to-equity
Mar 20231.04×
Dec 20230.77×
Mar 20240.74×
Jun 20240.68×
Sep 20246.47×
Dec 20246.53×
Mar 20256.46×
Jun 20255.94×
Sep 20255.22×
Dec 20255.01×
Mar 20264.68×
Jun 20264.23×
Top: total debt each quarter, $ B. Below: debt-to-equity, ×. Last 12 quarters.

What is the Concentra Group Holdings Parent shareholding pattern?

3.1% of Concentra Group Holdings Parent, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 3.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

3.1%Short interest · of the tradable float
3.0Days to cover · at typical volumes

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

How far is Concentra Group Holdings Parent from balance-sheet trouble?

For Concentra Group Holdings Parent, Inc., the Z-score is 2.03. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 2.03 is in the grey area, neither clearly safe nor clearly in trouble.

How does Concentra Group Holdings Parent rank in its industry?

71.9 out of 100, rank 1 of 30 in Medical Care Facilities, with 81% of the evidence available.

Concentra Group Holdings Parent, Inc. scores 71.9 out of 100 against the 30 companies it is compared with in Medical Care Facilities, ranking 1. Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.

The four parts add up to the total exactly: 24 + 16.6 + 12.8 + 18.5 = 71.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is Concentra Group Holdings Parent compared with?

Concentra Group Holdings Parent ranks 1 of 30 Medical Care Facilities companies on the 4-Factor Sector Score, with 71.9 out of 100.

  1. 1Concentra Group Holdings Parent, Inc. this pageCON · leader · Most evidence points up · 81% evidence71.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.0/35 · Revenue 14% · Profit 32.6% · Operating margin change 2.3 points · 83% evidenceCapital efficiency 16.6/25 · ROCE 14.5% · Operating margin 19.3% · 76% evidenceValuation 12.8/20 · P/E 19.5× · PEG 0.65 · 65% evidenceRelative strength 18.5/20 · Lead over its industry 20.3% · Lead over S&P 500 51% · 1 year 125.2% · 100% evidence · 12 of 12 weeks aheadExact sum: 24 + 16.6 + 12.8 + 18.5 = 71.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2Nutex Health Inc.NUTX · leader · Most evidence points up · 64% evidence66.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 22.5/35 · Revenue 6.8% · Profit 100% · Operating margin change 44 points · 62% evidenceCapital efficiency 18.7/25 · ROCE 56.8% · Operating margin 57.8% · 76% evidenceValuation 10.8/20 · P/E 6.5× · PEG — · 15% evidenceRelative strength 14.6/20 · Lead over its industry 1% · Lead over S&P 500 28% · 1 year 79% · 100% evidence · 12 of 12 weeks aheadExact sum: 22.5 + 18.7 + 10.8 + 14.6 = 66.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  3. 3Tenet Healthcare CorporationTHC · leader · Most evidence points up · 81% evidence65.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.8/35 · Revenue 5.4% · Profit 32.4% · Operating margin change 2.1 points · 83% evidenceCapital efficiency 17.1/25 · ROCE 15% · Operating margin 18.2% · 76% evidenceValuation 15.2/20 · P/E 7.2× · PEG 0.35 · 65% evidenceRelative strength 12.6/20 · Lead over its industry -1.3% · Lead over S&P 500 25.8% · 1 year 42.4% · 100% evidence · 12 of 12 weeks aheadExact sum: 20.8 + 17.1 + 15.2 + 12.6 = 65.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4AMN Healthcare Services, Inc.AMN · breaking out · Evidence leans up · 64% evidence64.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.4/35 · Revenue 23.9% · Profit — · Operating margin change 3.4 points · 62% evidenceCapital efficiency 9.1/25 · ROCE 10.1% · Operating margin 4% · 76% evidenceValuation 10.3/20 · P/E 12× · PEG — · 15% evidenceRelative strength 19.3/20 · Lead over its industry 36.3% · Lead over S&P 500 69.4% · 1 year 167.2% · 100% evidence · 9 of 12 weeks aheadExact sum: 25.4 + 9.1 + 10.3 + 19.3 = 64.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5Pediatrix Medical Group, Inc.MD · turning · Evidence leans up · 81% evidence61.9out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 19.1/35 · Revenue 0.6% · Profit 61.5% · Operating margin change -0.2 points · 83% evidenceCapital efficiency 14.6/25 · ROCE 14.8% · Operating margin 13.4% · 76% evidenceValuation 12.8/20 · P/E 11.6× · PEG 0.8 · 65% evidenceRelative strength 15.4/20 · Lead over its industry 1.6% · Lead over S&P 500 29.5% · 1 year 49.6% · 100% evidence · 8 of 12 weeks aheadExact sum: 19.1 + 14.6 + 12.8 + 15.4 = 61.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Healthcare Services Group, Inc.HCSG · turning · Evidence leans up · 85% evidence60.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 20.4/35 · Revenue 4% · Profit 100% · Operating margin change -3.2 points · 95% evidenceCapital efficiency 14.6/25 · ROCE 17.7% · Operating margin 6.7% · 76% evidenceValuation 14.3/20 · P/E 13.4× · PEG 0.43 · 65% evidenceRelative strength 11.0/20 · Lead over its industry -7.3% · Lead over S&P 500 18.3% · 1 year 53.8% · 100% evidence · 4 of 12 weeks aheadExact sum: 20.4 + 14.6 + 14.3 + 11 = 60.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Aveanna Healthcare Holdings Inc.AVAH · leader · Too little evidence to rank firmly · 58% evidence60.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 15.4/35 · Revenue — · Profit — · Operating margin change 1.6 points · 45% evidenceCapital efficiency 15.4/25 · ROCE 17.7% · Operating margin 12.6% · 76% evidenceValuation 10.6/20 · P/E 7.2× · PEG — · 15% evidenceRelative strength 18.6/20 · Lead over its industry 14.8% · Lead over S&P 500 45.2% · 1 year 62.6% · 100% evidence · 12 of 12 weeks aheadExact sum: 15.4 + 15.4 + 10.6 + 18.6 = 60 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
  8. 8Encompass Health CorporationEHC · leader · Evidence leans up · 81% evidence59.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 17.5/35 · Revenue 9.5% · Profit 20.2% · Operating margin change 0.3 points · 83% evidenceCapital efficiency 18.1/25 · ROCE 17% · Operating margin 18.1% · 76% evidenceValuation 12.2/20 · P/E 16.2× · PEG 0.8 · 65% evidenceRelative strength 11.6/20 · Lead over its industry -6.7% · Lead over S&P 500 19.5% · 1 year 22.3% · 100% evidence · 12 of 12 weeks aheadExact sum: 17.5 + 18.1 + 12.2 + 11.6 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  9. 9HCA Healthcare, Inc.HCA · breaking out · Evidence leans up · 81% evidence58.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 15.4/35 · Revenue 7.3% · Profit 14.6% · Operating margin change -0.7 points · 83% evidenceCapital efficiency 19.9/25 · ROCE 26.3% · Operating margin 15.2% · 76% evidenceValuation 14.2/20 · P/E 12.6× · PEG 0.49 · 65% evidenceRelative strength 8.8/20 · Lead over its industry -18.7% · Lead over S&P 500 5.4% · 1 year 7.2% · 100% evidence · 10 of 12 weeks aheadExact sum: 15.4 + 19.9 + 14.2 + 8.8 = 58.3 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far.
  10. 10Universal Health Services, Inc.UHS · breaking out · Evidence leans up · 81% evidence57.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 18.8/35 · Revenue 10% · Profit 21% · Operating margin change -0.6 points · 83% evidenceCapital efficiency 16.4/25 · ROCE 16.3% · Operating margin 11.1% · 76% evidenceValuation 15.9/20 · P/E 5.9× · PEG 0.2 · 65% evidenceRelative strength 6.6/20 · Lead over its industry -24.5% · Lead over S&P 500 -1.6% · 1 year -14.3% · 100% evidence · 11 of 12 weeks aheadExact sum: 18.8 + 16.4 + 15.9 + 6.6 = 57.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  11. 11LifeStance Health Group, Inc.LFST · turning · Evidence leans up · 64% evidence56.1out of 100GrowthCapitalValuationRelative
  12. 12Addus HomeCare CorporationADUS · turning · Evidence leans up · 81% evidence55.6out of 100GrowthCapitalValuationRelative
  13. 13PACS Group, Inc.PACS · turning · Evidence leans up · 71% evidence53.5out of 100GrowthCapitalValuationRelative
  14. 14National HealthCare CorporationNHC · quiet · Evidence leans up · 81% evidence53.1out of 100GrowthCapitalValuationRelative
  15. 15Fresenius Medical Care AGFMS · basing · Evidence leans up · 81% evidence50.7out of 100GrowthCapitalValuationRelative
  16. 16Guardian Pharmacy Services, Inc.GRDN · quiet · Evidence leans down · 64% evidence49.3out of 100GrowthCapitalValuationRelative
  17. 17Chemed CorporationCHE · turning · Evidence leans down · 81% evidence48.5out of 100GrowthCapitalValuationRelative
  18. 18Astrana Health, Inc.ASTH · turning · Evidence leans down · 81% evidence48.1out of 100GrowthCapitalValuationRelative
  19. 19Surgery Partners, Inc.SGRY · turning · Evidence leans down · 64% evidence48.1out of 100GrowthCapitalValuationRelative
  20. 20DaVita Inc.DVA · turning · Evidence leans down · 81% evidence47.9out of 100GrowthCapitalValuationRelative
  21. 21The Pennant Group, Inc.PNTG · turning · Evidence leans down · 81% evidence44.1out of 100GrowthCapitalValuationRelative
  22. 22The Ensign Group, Inc.ENSG · turning · Evidence leans down · 81% evidence41.8out of 100GrowthCapitalValuationRelative
  23. 23agilon health, inc.AGL · turning · Evidence leans down · 64% evidence41.3out of 100GrowthCapitalValuationRelative
  24. 24InnovAge Holding Corp.INNV · quiet · Evidence leans down · 64% evidence39.9out of 100GrowthCapitalValuationRelative
  25. 25Acadia Healthcare Company, Inc.ACHC · turning · Evidence leans down · 71% evidence39.4out of 100GrowthCapitalValuationRelative
  26. 26Option Care Health, Inc.OPCH · breaking out · Evidence leans down · 81% evidence39.3out of 100GrowthCapitalValuationRelative
  27. 27Ardent Health, Inc.ARDT · breaking out · Evidence leans down · 71% evidence37.8out of 100GrowthCapitalValuationRelative
  28. 28Sonida Senior Living, Inc.SNDA · quiet · Evidence leans down · 64% evidence36.8out of 100GrowthCapitalValuationRelative
  29. 29Brookdale Senior Living Inc.BKD · quiet · Most evidence points down · 64% evidence32.9out of 100GrowthCapitalValuationRelative
  30. 30Select Medical Holdings CorporationSEM · Too little evidence to rank firmly · 36% evidence50.6out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Medical Care Facilities, all 30 compared on one page.

Which companies are close to Concentra Group Holdings Parent in size?

Concentra Group Holdings Parent is the 10th largest of 38 Medical Care Facilities companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: The Ensign Group, Inc., PACS Group, Inc. and Chemed Corporation. Just below it: LifeStance Health Group, Inc., Option Care Health, Inc. and National HealthCare Corporation.

Medical Care Facilities companies close in size

  1. The Ensign Group, Inc. $10.9 billion
  2. PACS Group, Inc. $8 billion
  3. Chemed Corporation $7.1 billion
  4. Concentra Group Holdings Parent, Inc. $5.6 billion
  5. LifeStance Health Group, Inc. $5.4 billion
  6. Option Care Health, Inc. $4.7 billion
  7. National HealthCare Corporation $3.3 billion

All 38 Medical Care Facilities companies, largest first

Companies close in size in other industries

  1. Floor & Decor Holdings, Inc. $5.6 billion · Home Improvement Retail
  2. Impinj, Inc. $5.6 billion · Semiconductors
  3. Concentra Group Holdings Parent, Inc. $5.6 billion
  4. Magnolia Oil & Gas Corporation $5.5 billion · Oil & Gas Exploration & Production
  5. Parsons Corporation $5.5 billion · Information Technology Services

What else do people ask about Concentra Group Holdings Parent?

What were Concentra Group Holdings Parent's latest quarterly results?

Concentra Group Holdings Parent, Inc. reported revenue of $606 M and net profit of $63.9 M for the Jun 2026 quarter. Revenue rose 10.0% and profit rose 45.2% compared with a year earlier. Earnings per share were $0.51 (as of 4 November 2026).

What is Concentra Group Holdings Parent's market cap?

Concentra Group Holdings Parent, Inc.'s market capitalisation is $5.6 B at a stock price of $43.56. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is Concentra Group Holdings Parent performing?

Concentra Group Holdings Parent, Inc.'s share price has been rising for 24 weeks. In its latest quarter, revenue rose 10.0% and profit rose 45.2% compared with a year earlier.

Over the past 13 weeks it has done better than the S&P 500, for 23 weeks running (as of 4 November 2026).

Will Concentra Group Holdings Parent's stock price go up?

This page does not forecast Concentra Group Holdings Parent, Inc.'s stock price. What it shows instead: the stock price is $43.56, and it has been rising for 24 weeks. Its P/E of 28.5× is higher than 100% of its own last 2 years (as of 4 November 2026).

Where is Concentra Group Holdings Parent in its business cycle?

Concentra Group Holdings Parent, Inc.'s FY25 operating margin was 16.0%, against a 5-year range of 15.0% to 21.9%: the low end of its own range, which is often where recoveries start. The latest quarter was 19.3%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the Concentra Group Holdings Parent story?

The main question: the share price moved +125.2% in a year while yearly earnings per share moved −12.1%. The difference came from the market paying a higher multiple.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is Concentra Group Holdings Parent a stock worth studying right now?

What the numbers show: Concentra Group Holdings Parent, Inc.'s share price has risen faster than its earnings: +125.2% in a year, against −12.1% for earnings per share. The main open question: whether earnings grow into a price that has already moved.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.